Gene Therapy for Restenosis
- 28 April 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 86 (8) , 829-833
- https://doi.org/10.1161/01.res.86.8.829
Abstract
This review provides an overview of candidate genes that are currently being evaluated for genetic strategies in vascular gene therapy. We discuss treatment strategies that have proven efficacious in limiting postinterventional restenosis through evaluation with in vivo model systems. The candidate strategies utilize genes that are either cytotoxic, regulate vascular smooth muscle cell differentiation or proliferation. In addition, we review oligonuclotide and ribozyme strategies that function by suppressing the expression of cell cycle regulators.Keywords
This publication has 24 references indexed in Scilit:
- Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injuryGene Therapy, 1999
- Dual role of Ras and Rho proteins: At the cutting edge of life and deathImmunology & Cell Biology, 1998
- Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplastyCardiovascular Research, 1997
- Accelerated Endothelialization by Local Delivery of Recombinant Human Vascular Endothelial Growth Factor Reduces In-Stent Intimal FormationBiochemical and Biophysical Research Communications, 1997
- Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.Journal of Clinical Investigation, 1997
- Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injuryJournal of Vascular Surgery, 1997
- Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries.Journal of Clinical Investigation, 1996
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Journal of Clinical Investigation, 1995
- Antisense Oligonucleotides to the P65 Subunit of NF-κb Inhibit Human Vascular Smooth Muscle Cell Adherence and Proliferation and Prevent Neointima Formation in Rat Carotid ArteriesBiochemical and Biophysical Research Communications, 1995
- Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial InjuryScience, 1994